Ausgabe 1/1997
Inhalt (8 Artikel)
A novel immunotoxin recognising the epithelial glycoprotein-2 has potent antitumoural activity on chemotherapy-resistant lung cancer
Sandra Zimmermann, Winfried Wels, Barbara A. Froesch, Bernd Gerstmayer, Rolf A. Stahel, U. Zangemeister-Wittke
A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy
K. A. O. Ellem, Michael G. E. O’Rourke, Gregory R. Johnson, Gordon Parry, Ihor S. Misko, Christopher W. Schmidt, Peter G. Parsons, Scott R. Burrows, Simone Cross, Andrew Fell, Chung-Leung Li, John R. Bell, Philip J. Dubois, Denis J. Moss, Michael F. Good, Anne Kelso, Lawrence K. Cohen, Glenn Dranoff, Richard C. Mulligan
Efficient induction of antitumor cytoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro
F. Tanaka, Tatsuo Fujie, Hiroki Go, Kinya Baba, Masaki Mori, Kazutoh Takesako, Tsuyoshi Akiyoshi
Characterisation of γδ T cells in renal cell carcinoma patients by polymerase chain reaction analysis of T cell receptor transcripts
C. Olive, David Nicol, Michael C. Falk
Effects of colony-stimulating factors on cellular cytotoxicity
Christoph Durek, Ingmar Schäfer, Henning Braasch, Artur J. Ulmer, Martin Ernst, Hans-Dieter Flad, Dieter Jocham, A. Böhle
Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia
X.-L. Zhang, Y. Komada, Yan-Wen Zhou, Tong-Xin Chen, Haruko Sakai, Eiichi Azuma, Masaru Ido, Minoru Sakurai
Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanoma
T. Sakurai, Muneo Yamada, Seiichi Simamura, Kazuo Motoyoshi
Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics
Wilfried Roth, Adriano Fontana, Martin Trepel, John C. Reed, Johannes Dichgans, M. Weller